Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
DCM Shriram Limited (DCMSHRIRAM.NS)
New Delhi, DE, IN
DCM Shriram Limited is an Indian conglomerate with a diverse business portfolio, operating both domestically and internationally in sectors such as chloro-vinyl products, sugar, agricultural inputs, and various other enterprises. The company organizes its extensive operations through several key segments, including Fertilisers, Chloro-Vinyl, Shriram Farm Solutions, Sugar, Bioseed, and additional ventures. Its manufacturing output encompasses urea, a range of chloro-vinyl derivatives like caustic soda (both lye and flakes), chlorine, hydrogen, stable bleaching powder, calcium carbide, PVC resins, and aluminum chloride. In the sugar industry, it produces sugar and ethanol, and generates power from bagasse-based co-generation plants. For the agricultural sector, DCM Shriram offers plant nutrition solutions, crop protection chemicals, and hybrid seeds. Additionally, the company manufactures UPVC and aluminum windows and doors, and engages in the retail of fuels such as petrol and diesel. Established in 1989, the New Delhi-based entity was formerly known as DCM Shriram Consolidated Limited and currently operates as a subsidiary of Sumant Investments Private Limited.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.46% | -8.60% | -10.14% | -0.59% | -7.65% | -12.19% | +3.22% | +33.74% | +63.49% | +517.35% | +17,214.96% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+12.1% ★ Q1'26: +11.0% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+41.2% ★ Q1'26: +106.7% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+2.9% Q1'26: +36.7% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+7.4% Q1'26: +6.7% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+8.8% ★ Q1'26: +8.8% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×1.95× Q1'26: 2.07× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2006 actual |
Mar 2007 actual |
Mar 2014 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
Mar 2031 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
23.92B
est: 24.27B (-1.4%)
|
27.67B
est: 26.18B (+5.7%)
|
56.06B
est: 58.83B (-4.7%)
|
56.06B
est: 55.14B (+1.7%)
|
57.80B
est: 59.55B (-2.9%)
|
57.88B
est: 57.60B (+0.5%)
|
69.00B
est: 72.65B (-5.0%)
|
77.71B
est: 59.55B (+30.5%)
|
77.67B
est: 57.60B (+34.8%)
|
83.08B
est: 72.65B (+14.4%)
|
96.27B
est: 77.93B (+23.5%)
|
115.47B
est: 77.50B (+49.0%)
|
109.22B
est: 89.59B (+21.9%)
|
120.77B
est: 59.55B (+102.8%)
|
140.15B
140.15B – 140.15B
+135.4% YoY
|
154.77B
154.77B – 154.77B
+10.4% YoY
|
72.65B
72.65B – 72.65B
-53.1% YoY
|
77.93B
77.93B – 77.93B
+7.3% YoY
|
77.50B
77.50B – 77.50B
-0.6% YoY
|
89.59B
89.59B – 89.59B
+15.6% YoY
|
| EBITDA |
3.19B
est: 3.17B (+0.7%)
|
2.54B
est: 3.35B (-24.2%)
|
4.01B
est: 7.53B (-46.7%)
|
4.01B
est: 7.20B (-44.3%)
|
5.23B
est: 7.77B (-32.7%)
|
7.78B
est: 5.59B (+39.2%)
|
10.36B
est: 8.92B (+16.1%)
|
13.67B
est: 10.16B (+34.6%)
|
11.87B
est: 12.84B (-7.5%)
|
11.15B
est: 9.48B (+17.6%)
|
17.63B
est: 12.54B (+40.6%)
|
15.84B
est: 10.11B (+56.6%)
|
9.63B
est: 11.69B (-17.6%)
|
13.26B
est: 7.49B (+77.0%)
|
17.63B
17.63B – 17.63B
+135.4% YoY
|
19.47B
19.47B – 19.47B
+10.4% YoY
|
9.14B
9.14B – 9.14B
-53.1% YoY
|
9.80B
9.80B – 9.80B
+7.3% YoY
|
9.75B
9.75B – 9.75B
-0.6% YoY
|
11.27B
11.27B – 11.27B
+15.6% YoY
|
| EBIT |
2.46B
est: 2.56B (-4.2%)
|
1.61B
est: 2.71B (-40.8%)
|
2.91B
est: 6.09B (-52.3%)
|
2.91B
est: 5.82B (-50.1%)
|
4.27B
est: 6.29B (-32.1%)
|
6.72B
est: 3.79B (+77.1%)
|
9.04B
est: 8.40B (+7.6%)
|
12.20B
est: 9.45B (+29.0%)
|
9.98B
est: 12.33B (-19.1%)
|
9.11B
est: 7.67B (+18.7%)
|
15.50B
est: 12.15B (+27.6%)
|
13.47B
est: 8.19B (+64.6%)
|
6.86B
est: 9.46B (-27.5%)
|
9.42B
est: 5.86B (+60.8%)
|
13.79B
13.79B – 13.79B
+135.4% YoY
|
15.23B
15.23B – 15.23B
+10.4% YoY
|
7.15B
7.15B – 7.15B
-53.1% YoY
|
7.67B
7.67B – 7.67B
+7.3% YoY
|
7.63B
7.63B – 7.63B
-0.6% YoY
|
8.82B
8.82B – 8.82B
+15.6% YoY
|
| Net Income |
1.21B
est: 1.15B (+5.7%)
|
434.00M
est: 775.58M (-44.0%)
|
2.11B
est: 2.17B (-2.8%)
|
2.11B
est: 2.67B (-20.9%)
|
3.02B
est: 2.65B (+13.8%)
|
5.52B
est: 2.84B (+94.5%)
|
6.70B
est: 6.99B (-4.2%)
|
9.06B
est: 7.03B (+28.8%)
|
7.17B
est: 9.20B (-22.1%)
|
6.73B
est: 8.81B (-23.6%)
|
10.67B
est: 9.00B (+18.6%)
|
9.11B
est: 6.55B (+39.1%)
|
4.47B
est: 8.86B (-49.5%)
|
6.04B
est: 2.65B (+127.9%)
|
13.05B
13.05B – 13.05B
+392.4% YoY
|
15.16B
15.16B – 15.16B
+16.1% YoY
|
8.81B
8.81B – 8.81B
-41.9% YoY
|
8.83B
8.83B – 8.83B
+0.2% YoY
|
6.55B
6.55B – 6.55B
-25.9% YoY
|
8.86B
8.86B – 8.86B
+35.2% YoY
|
| SGA |
—
est: 2.08B (-100.0%)
|
—
est: 2.20B (-100.0%)
|
4.70B
est: 4.94B (-4.9%)
|
4.70B
est: 4.72B (-0.5%)
|
5.12B
est: 5.10B (+0.5%)
|
5.59B
est: 3.19B (+75.4%)
|
6.28B
est: 10.46B (-40.0%)
|
6.64B
est: 8.71B (-23.8%)
|
7.41B
est: 12.07B (-38.6%)
|
7.35B
est: 6.22B (+18.1%)
|
7.86B
est: 15.19B (-48.2%)
|
8.98B
est: 6.64B (+35.4%)
|
9.92B
est: 7.67B (+29.3%)
|
10.81B
est: 5.73B (+88.6%)
|
13.48B
13.48B – 13.48B
+135.4% YoY
|
14.89B
14.89B – 14.89B
+10.4% YoY
|
6.99B
6.99B – 6.99B
-53.1% YoY
|
7.50B
7.50B – 7.50B
+7.3% YoY
|
7.46B
7.46B – 7.46B
-0.6% YoY
|
8.62B
8.62B – 8.62B
+15.6% YoY
|
| EPS |
7.12
est: 7.34 (-3.1%)
|
2.63
est: 5.00 (-47.4%)
|
12.97
est: 13.97 (-7.2%)
|
12.97
est: 17.10 (-24.2%)
|
18.58
est: 17.00 (+9.3%)
|
33.97
est: 30.49 (+11.4%)
|
41.22
est: 56.51 (-27.1%)
|
57.09
est: 17.00 (+235.8%)
|
45.96
est: 30.49 (+50.8%)
|
43.17
est: 56.51 (-23.6%)
|
68.45
est: 56.65 (+20.8%)
|
58.41
est: 42.00 (+39.1%)
|
28.67
est: 56.80 (-49.5%)
|
38.75
est: 17.00 (+127.9%)
|
83.70
83.70 – 83.70
+392.4% YoY
|
97.20
97.20 – 97.20
+16.1% YoY
|
56.51
56.51 – 56.51
-41.9% YoY
|
56.65
56.65 – 56.65
+0.2% YoY
|
42.00
42.00 – 42.00
-25.9% YoY
|
56.80
56.80 – 56.80
+35.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-18 | B | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-15 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.01% | 1.34M | 0.06% |
| 2 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 4.90M | 0.06% |
| 3 | Vanguard ESG International Stock ETF VSGX | 0.00% | 70.5K | 0.10% |
| 4 | Vanguard Total International Stock ETF VXUS | 0.00% | 5.45M | 0.05% |
| 5 | Vanguard Total World Stock ETF VT | 0.00% | 355.2K | 0.06% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Vikram Shridhar Shriram | Vice Chairman & MD | 165M | male |
| Ajay Shridhar Shriram | Chairman, Chief Executive Officer & Senior MD | 164M | male |
| Ajit Shridhar Shriram | Joint MD & Executive Director | 150M | male |
| Aditya A. Shriram | Deputy MD & Director | 32M | male |
| Krishan Kumar Sharma | Whole Time Director of Environment, Health & Safety | 15M | male |
| Ankush Kaura | Executive Director & Chief Information Officer | — | male |
| Bineet Khurana | Senior Vice President & Head - Legal | — | male |
| Deepak Gupta | Vice President - Corporate Law and Company Secretary & Compliance Officer | — | male |
| Sridhar Kumar Namburi | President and Head of Internal Audit & Risk Management | — | male |
| Amit Agarwal | Executive Director & Group Chief Financial Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for DCMSHRIRAM.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
